Spots Global Cancer Trial Database for An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

Official Title: Can MRI Replace CT in the Evaluation of Thymoma?

Study ID: NCT03968315

Conditions

Recurrent Malignant Thymoma

Thymoma

Interventions

Diaphragm Fluoroscopy

Magnetic Resonance Imaging

Study Description

Brief Summary: This trial studies the accuracy of a magnetic resonance imaging (MRI) scan in imaging the inside of the chest in patients with thymoma that is newly diagnosed or has come back. An MRI scan may be able to detect if and how far the tumor has spread more accurately than a standard computed tomography (CT) scan.

Detailed Description: PRIMARY OBJECTIVES: I. To determine whether thymoma staging by MRI is as accurate as staging by CT as compared to surgical staging. SECONDARY OBJECTIVES: I. To determine whether evaluation of phrenic nerve paralysis by functional MRI is as accurate as the fluoroscopic "sniff test" as compared to surgical evaluation of phrenic nerve involvement. II. To determine whether fast novel MRI sequences are as accurate as conventional MRI sequences for staging thymoma, when comparing to surgical staging. OUTLINE: Patients undergo an MRI scan over 45-60 minutes and a diaphragm fluoroscopy 30 days before surgery.